Viral Vector And Plasmid Dna Manufacturing Market

Table of Contents

1 Executive Summary          
            
2 Preface           
 2.1 Abstract          
 2.2 Stake Holders         
 2.3 Research Scope         
 2.4 Research Methodology        
  2.4.1 Data Mining        
  2.4.2 Data Analysis        
  2.4.3 Data Validation        
  2.4.4 Research Approach        
 2.5 Research Sources         
  2.5.1 Primary Research Sources       
  2.5.2 Secondary Research Sources       
  2.5.3 Assumptions        
            
3 Market Trend Analysis         
 3.1 Introduction         
 3.2 Drivers          
 3.3 Restraints         
 3.4 Opportunities         
 3.5 Threats          
 3.6 Application Analysis        
 3.7 End User Analysis         
 3.8 Emerging Markets         
 3.9 Impact of Covid-19         
             
4 Porters Five Force Analysis         
 4.1 Bargaining power of suppliers        
 4.2 Bargaining power of buyers        
 4.3 Threat of substitutes        
 4.4 Threat of new entrants        
 4.5 Competitive rivalry         
            
5 Global Viral Vector & Plasmid DNA Manufacturing Market, By Vector Type    
 5.1 Introduction         
 5.2 Viral Vectors         
  5.2.1 Lentiviral Vectors        
  5.2.2 Adenoviral Vectors        
  5.2.3 Retroviral Vectors        
  5.2.4 Adeno-Associated Virus (AAV)      
  5.2.5 Other Viral Vectors        
   5.2.5.1 Simian Virus       
   5.2.5.2 Alphavirus       
   5.2.5.3 Herpes Simplex Virus      
   5.2.5.4 Sendai Virus       
   5.2.5.5 Foamy Virus       
   5.2.5.6 Vaccinia Virus        
 5.3 Non-Viral Vectors         
  5.3.1 Plasmid DNA        
  5.3.2 Liposomes, Lipoplexes and Polyplexes      
  5.3.3 Oligonucleotides        
            
6 Global Viral Vector & Plasmid DNA Manufacturing Market, By Workflow     
 6.1 Introduction         
 6.2 Downstream Processing          
  6.2.1 Fill-Finish          
  6.2.2 Purification          
 6.3 Upstream Processing          
  6.3.1 Vector Recovery/Harvesting        
  6.3.2 Vector Amplification & Expansion      
             
7 Global Viral Vector & Plasmid DNA Manufacturing Market, By Disease     
 7.1 Introduction         
 7.2 Infectious Diseases         
 7.3 Cancer           
 7.4 Genetic Disorders         
            
8 Global Viral Vector & Plasmid DNA Manufacturing Market, By Sales Channel    
 8.1 Introduction         
 8.2 Direct Sales         
 8.3 Channel Sales         
            
9 Global Viral Vector & Plasmid DNA Manufacturing Market, By Application    
 9.1 Introduction         
 9.2 Vaccinology          
 9.3 Antisense & RNAi, & Molecular Therapy       
 9.4 Cell Therapy         
 9.5 Cancer          
 9.6 Viral Infections         
 9.7 Gene Therapy         
 9.8 Inherited Disorders         
 9.9 Viral Vaccines         
 9.10 Protein Expression Studies        
 9.11 Formulation Development        
            
10 Global Viral Vector & Plasmid DNA Manufacturing Market, By End User     
 10.1 Introduction         
 10.2 Pharmaceutical and Biopharmaceutical Companies         
 10.3 Research Institutes         
 10.4 Immunotherapy         
 10.5 DNA Vaccines         
 10.6 Hospitals          
            
11 Global Viral Vector & Plasmid DNA Manufacturing Market, By Geography    
 11.1 Introduction         
 11.2 North America          
  11.2.1 US         
  11.2.2 Canada         
  11.2.3 Mexico         
 11.3 Europe          
  11.3.1 Germany         
  11.3.2 UK         
  11.3.3 Italy         
  11.3.4 France         
  11.3.5 Spain         
  11.3.6 Rest of Europe         
 11.4 Asia Pacific         
  11.4.1 Japan         
  11.4.2 China         
  11.4.3 India         
  11.4.4 Australia         
  11.4.5 New Zealand        
  11.4.6 South Korea        
  11.4.7 Rest of Asia Pacific        
 11.5 South America         
  11.5.1 Argentina        
  11.5.2 Brazil         
  11.5.3 Chile         
  11.5.4 Rest of South America       
 11.6 Middle East & Africa        
  11.6.1 Saudi Arabia        
  11.6.2 UAE         
  11.6.3 Qatar         
  11.6.4 South Africa        
  11.6.5 Rest of Middle East & Africa       
            
12 Key Developments          
 12.1 Agreements, Partnerships, Collaborations and Joint Ventures     
 12.2 Acquisitions & Mergers        
 12.3 New Product Launch         
 12.4 Expansions         
 12.5 Other Key Strategies        
            
13 Company Profiling          
 13.1 Lonza          
 13.2 Catapult           
 13.3 uniQure N.V.         
 13.4 FUJIFILM Diosynth Biotechnologies       
 13.5 Kaneka Eurogentec S.A.        
 13.6 Oxford Biomedica         
 13.7 Spark Therapeutics, Inc.        
 13.8 Cobrabiologics         
 13.9 Merck KGaA         
 13.10 Brammer Bio         
 13.11 Cell and Gene Therapy Catapult       
 13.12 FinVector Vision Therapies        
 13.13 MassBiologics         
 13.14 SIRION Biotech         
 13.15 Thermo Fisher Scientific       

List of Tables           
1 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Region (2017-2027) ($MN)  
2 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Vector Type (2017-2027) ($MN)  
3 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Viral Vectors (2017-2027) ($MN)  
4 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Lentiviral Vectors (2017-2027) ($MN) 
5 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Adenoviral Vectors (2017-2027) ($MN) 
6 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Retroviral Vectors (2017-2027) ($MN) 
7 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Adeno-Associated Virus (AAV) (2017-2027) ($MN)
8 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Other Viral Vectors (2017-2027) ($MN) 
9 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Non-Viral Vectors (2017-2027) ($MN) 
10 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Plasmid DNA (2017-2027) ($MN)  
11 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Liposomes, Lipoplexes and Polyplexes (2017-2027) ($MN)
12 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Oligonucleotides (2017-2027) ($MN) 
13 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Workflow (2017-2027) ($MN)  
14 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Downstream Processing (2017-2027) ($MN) 
15 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Fill-Finish (2017-2027) ($MN)  
16 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Purification (2017-2027) ($MN)  
17 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Upstream Processing (2017-2027) ($MN) 
18 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Vector Recovery/Harvesting (2017-2027) ($MN)
19 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Vector Amplification & Expansion (2017-2027) ($MN)
20 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Disease (2017-2027) ($MN)  
21 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Infectious Diseases (2017-2027) ($MN) 
22 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Cancer (2017-2027) ($MN)  
23 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Genetic Disorders (2017-2027) ($MN) 
24 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Sales Channel (2017-2027) ($MN)  
25 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Direct Sales (2017-2027) ($MN)  
26 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Channel Sales (2017-2027) ($MN)  
27 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Application (2017-2027) ($MN)  
28 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Vaccinology (2017-2027) ($MN)  
29 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Antisense & RNAi, & Molecular Therapy (2017-2027) ($MN)
30 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Cell Therapy (2017-2027) ($MN)  
31 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Cancer (2017-2027) ($MN)  
32 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Viral Infections (2017-2027) ($MN) 
33 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Gene Therapy (2017-2027) ($MN)  
34 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Inherited Disorders (2017-2027) ($MN) 
35 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Viral Vaccines (2017-2027) ($MN)  
36 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Protein Expression Studies (2017-2027) ($MN)
37 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Formulation Development (2017-2027) ($MN)
38 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By End User (2017-2027) ($MN)  
39 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Pharmaceutical and Biopharmaceutical Companies (2017-2027) ($MN)
40 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Research Institutes (2017-2027) ($MN) 
41 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Immunotherapy (2017-2027) ($MN) 
42 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By DNA Vaccines (2017-2027) ($MN)  
43 Global Viral Vector & Plasmid DNA Manufacturing Market Outlook, By Hospitals (2017-2027) ($MN)  
            
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

• Product Lifecycle Analysis
• Competitor analysis
• Risk analysis
• Porters Analysis
• PESTEL Analysis
• SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.

Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

• Leading Companies
• Suppliers & Distributors
• Manufacturers
• Consumers
• Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.

For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.